S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

MRVI Maravai LifeSciences Holdings Inc

7.70

0.12 (1.58%)

27 Apr 2024 - Closed

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Maravai LifeSciences Charts.

Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Maravai LifeSciences Charts.

Maravai LifeSciences Holdings Inc News

TriLink BioTechnologies® annonce un nouveau site à San Diego pour la production de substances médicamenteuses à base d'ARNm au stade ultime de leur développement
Friday 19 April 2024 (1 week ago) • Business Wire

TriLink BioTechnologies® kündigt neue Anlage in San Diego zur mRNA-Produktion von Arzneimittelwirkstoffen in der Spätphase an
Friday 19 April 2024 (1 week ago) • Business Wire

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
Thursday 18 April 2024 (1 week ago) • Business Wire

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
Thursday 11 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Maravai LifeSciences Announces March 2024 Investor Conference Schedule
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 23 February 2024 (2 months ago) • Edgar (US Regulatory)

Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
Friday 23 February 2024 (2 months ago) • GlobeNewswire Inc.

TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
Thursday 22 February 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 21 February 2024 (2 months ago) • Edgar (US Regulatory)

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
Wednesday 14 February 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Friday 9 February 2024 (3 months ago) • Edgar (US Regulatory)

More Maravai LifeSciences Holdings Inc News Articles

Gold vs US Dollar

Newcrest Mining

AUD vs US Dollar

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions